Amiselimod

amiselimod · Bausch Health Americas, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amiselimod, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis [Phase 2]